- A retrospective study to assess relative dose intensities in patients with lymphoma in central European countriesPublication without faculty affiliation
- Survival is correlated with average relative dose intensity in diffuse large B-cell lymphoma patients treated by CHOP: A national retrospective study (1995-2000)Publication without faculty affiliation
- A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma2021 | First Faculty of Medicine
- Pegfilgrastrim, lipegfilgrastim, febrile neutropenia, keeping chemotherapy dose intensity and COVID-19 in addition to it2020 | Faculty of Medicine in Pilsen
- Risk of febrile neutropenia and its prophylaxis during chemotherapy for breast cancer2023 | Faculty of Medicine in Pilsen
- Febrile neutropenia - new notes on prophylaxis with growth factors of granulopoiesis2023 | Faculty of Medicine in Pilsen
- Safety and efficacy of tafasitamab with or without lenalidomide added to first-line R-CHOP for DLBCL: the phase 1b First-MIND study2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Carboplatin with intravenous and subsequent oral administration of vinorelbine in resected non-small-cell-lung cancer in real-world set-up2017 | Publication without faculty affiliation
- Contribution of MEK Inhibition to BRAF/MEK Inhibitor Combination Treatment of BRAF-Mutant Melanoma: Part 2 of the Randomized, Open-Label, Phase III COLUMBUS Trial2023 | First Faculty of Medicine